NEW YORK , July 20, 2026 /PRNewswire/ --
NEW YORK , July 14, 2026 /PRNewswire/ --
NEW YORK , July 10, 2026 /PRNewswire/ --
NEW YORK , June 29, 2026 /PRNewswire/ --
NEW YORK , June 24, 2026 /PRNewswire/ --
NEW YORK , June 19, 2026 /PRNewswire/ --
NEW YORK , June 14, 2026 /PRNewswire/ --
Data from the RALLY-MF trial of DISC-0974 in patients with myelofibrosis (MF) and anemia demonstrate meaningful, durable overall anemia responses across all patient subgroups, regardless of baseline transfusion...
Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approval On track for expected CRL response submission...
NEW YORK , June 8, 2026 /PRNewswire/ --